This inventor holds 2 USPTO granted patents. Top assignee: Research, Incorporated. Active years: 1983-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1983-1987
Title: George H. Cocolas: Innovator in Antihyperlipidemic Research
Introduction
George H. Cocolas is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of controlling hyperlipidemia. With a total of 2 patents to his name, Cocolas has developed innovative processes and compositions that address critical health issues.
Latest Patents
Cocolas's latest patents include a process for controlling hyperlipidemia in mammals. This process involves treating mammals suffering from hyperlipidemia with a hyperlipidemia-controlling effective amount of a specific compound. The structural formula of the compound includes various functional groups, such as mercapto, amino, hydroxy, and alkylthio. Additionally, he has developed antihyperlipidemic compositions that consist of cyclic imides, diones, reduced diones, and their analogs, which are effective in reducing serum cholesterol and triglycerides.
Career Highlights
George H. Cocolas is associated with Research, Incorporated, where he has been instrumental in advancing research in antihyperlipidemic agents. His work has contributed to the development of pharmaceutical solutions that aim to improve health outcomes for individuals with high cholesterol and triglyceride levels.
Collaborations
Cocolas has collaborated with notable colleagues, including Iris H. Hall and James M. Chapman, Jr. These collaborations have further enhanced the research and development of innovative pharmaceutical compositions.
Conclusion
George H. Cocolas is a distinguished inventor whose work in antihyperlipidemic research has led to valuable patents and advancements in the pharmaceutical industry. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile